Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

MammaPrint Test

  • Manfred Schwab
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_7029-2


The MammaPrint test analyzes 70 genes from an early-stage breast cancer tissue sample to figure out if the cancer has a low or high risk of coming back (recurrence) within 10 years after diagnosis.

MammaPrint test results, when considered with other features of the cancer, can assist in making a more informed decision about whether chemotherapy or other treatments to reduce the risk of recurrence are good choices.

Who is Eligible for the MammaPrint Test?

MammaPrint can only be used to analyze early-stage breast cancer ( Early Detection). In the United States, MammaPrint can be used on cancers that are
  • Stage I or stage II

  • Invasive

  • Smaller than 5 cm

  • Lymph node negative (no cancer in the lymph nodes)

Women diagnosed with cancer must be 61 or younger.

Internationally, MammaPrint can be used on cancers that are
  • Stage I or stage II

  • Invasive

  • Smaller than 5 cm

  • In three or fewer lymph nodes

In both the United States and internationally, MammaPrint can be used to analyze cancers that...


Breast Cancer Lymph Node United States Early Detection Hormone Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

See Also

  1. (2012) Gene expression profiling. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1522. doi: 10.1007/978-3-642-16483-5_2368Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.German Cancer Research Center (DKFZ)HeidelbergGermany